Global X MSCI Argentina ETF vs Chewy Inc — how do they compare? Global X MSCI Argentina ETF trades at $91.63, while Chewy Inc trades at $22.28 (market cap $9.20B). The key difference: Global X MSCI Argentina ETF is trading nearer its 52-week high, Chewy Inc nearer its low. Which is the better fit depends on your goals.
| ARGT | CHWY | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Cyclical |
52-Week High | $102.94 | $42.33 |
52-Week Low | $67.55 | $17.51 |
Market Cap | — | $9.20B |
Enterprise Value | — | $9.16B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Chewy (CHWY) trades at $22.59, down 3.99% on the day, reflecting near-term bearish technical pressure. The stock shows strong fundamental progress with revenue climbing to $11.86B in 2025 and net income surging to $392.74M, marking a significant profitability turnaround. Recent earnings beats in Q3 2025 and Q1 2026 contrast with a Q4 2025 miss, indicating volatility. Analyst sentiment remains overwhelmingly positive with an 81.58% buy rating and a $33.82 consensus price target, suggesting substantial upside potential from current levels.
The investment outlook for CHWY is constructive, driven by robust revenue growth, expanding margins, and strong analyst conviction. Key opportunities include the company's dominant position in the pet care e-commerce space and its high customer loyalty through the Autoship subscription model. Primary risks involve competitive pressures from larger retailers, execution challenges in integrating veterinary services, and sensitivity to consumer spending trends. The stock presents a growth opportunity but requires monitoring of quarterly execution against high expectations.
Trailing returns across standard periods
ARGT seeks to provide investment results that correspond to the performance of the MSCI All Argentina 25/50 Index. It offers targeted exposure to some of the largest and most liquid companies operating in Argentina.
Read more on ARGT →Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Read more on CHWY →